Torrent Pharmaceuticals , a prominent player in the Indian pharmaceutical industry, has successfully redeemed Commercial Papers (CPs) worth ₹200.00 crores on their maturity date. The company made this announcement through a notification to the stock exchanges BSE and NSE on December 23, 2025.

Latest Redemption Details

The Commercial Papers, issued under ISIN: INE685A14179, were fully redeemed and repaid by Torrent Pharmaceuticals on the maturity date of December 23, 2025. This action demonstrates the company's commitment to meeting its financial obligations in a timely manner.

Regulatory Compliance

The redemption was announced pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification was signed by Chintan M. Trivedi, Company Secretary of Torrent Pharmaceuticals Limited, ensuring proper regulatory compliance and transparency.

Financial Implications

The successful redemption of these Commercial Papers on their maturity date reflects positively on Torrent Pharmaceuticals' liquidity management and financial health. It indicates the company's ability to honor its short-term debt obligations, which is crucial for maintaining investor confidence and financial stability.

About Torrent Pharmaceuticals

Torrent Pharmaceuticals Limited is a well-established pharmaceutical company based in Ahmedabad, India. The company operates in various therapeutic segments and maintains a strong commitment to delivering quality healthcare solutions. With its registered office at Torrent House, Off Ashram Road, Ahmedabad, the company continues to demonstrate financial discipline through timely debt servicing.

Torrent Pharmaceuticals has completed the redemption of secured redeemable non-convertible debentures (NCDs) worth ₹142.84 crores on December 12, 2025. The pharmaceutical company informed both BSE and NSE about this corporate action through an official communication.

Debenture Redemption Details

The redemption covers a portion of the company's debt securities, with key parameters outlined below:

The redeemed amount represents 14.28% of the total non-convertible debentures issued by the company under the specified ISIN.

Regulatory Compliance

Torrent Pharmaceuticals has fulfilled its disclosure obligations under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company notified both major stock exchanges where its shares are listed:

• BSE Limited (Scrip Code: 500420)
• National Stock Exchange of India (Scrip Code: TORNTPHARM)

The redemption and repayment were completed as scheduled. Company Secretary Chintan M. Trivedi signed the official communication to the exchanges.

Financial Impact

This redemption reduces the company's outstanding debt by ₹142.84 crores, leaving approximately ₹857.16 crores in NCDs still outstanding from the original ₹1,000 crores issue.